Life Healthcare disappoints investors despite big jump in earnings

Shares in the private hospital group Mediclinic’s share price fell on Wednesday morning after it released a trading update

AfroCentric has reached an agreement to fully take over drug importer Activo, positioning itself to compete with pharmaceutical giants

AfroCentric's principal subsidiary is medical scheme company Medscheme

Zambia aims to eradicate malaria, the country’s biggest killer, within three years

The Chinese maker of valsartan recalled the product from consumers in the US in July because an impurity linked to cancer had been detected

The private hospital group’s European operations outperform its SA unit

The Janssen vaccines unit and specialists at the Jenner Institute were involved in developing an Ebola vaccine in 2014, and the hope is that some of that ...

Private hospital group says earnings for the year to September 30 would fall slightly compared with the year before

Ascendis Health CEO Thomas Thomsen talks to Business Day TV about the group’s full-year results

Ascendis has already sold its sports nutrition business in SA and its direct-selling unit

The Swiss drugmaker's restructuring comes as part of a programme announced in 2016 to save about $1bn annually

Revenue climbs 21% to R7.7bn in the year to end-August, boosted by its acquisitions of higher margin businesses

The company’s shares have gained nearly 60% this year, after surging almost 300% in 2017

Stake in Max Healthcare finally to be sold to investment firm Kohlberg Kravis Roberts after tepid returns

Aspen announced last week that it would sell its baby-formula unit at a price the market perceived to be too low

Discovery Health CEO Jonathan Broomberg says the scheme’s administrator estimates total medical inflation for 2018 at between 11.2% and 12.2%